Orchestra BioMed™ Announces Completion of $41 Million Financing.
November 15, 2018
Capital proceeds to support late-stage clinical development of lead cardiovascular product candidates for artery disease and hypertensionFinancing structure provides for up to...
Immunomedics Chairman Buys $19 Million More in Stock.
(Barrons) Two weeks ago, B. Riley analyst Madhu Kumar gushed about Immunomedics, writing in a report that the biotech could have a “blockbuster cancer drug” in IMMU-132, an antibody-drug...
Steven Boyd, Armistice Capital Ranked #2 in Rising Hedge Fund Stars (Institutional Investor Magazine).
A handful were born outside the U.S., while others are first-generation Americans. Some were shoo-ins for the Ivy League, while several relied on athletic...
Internet Stock Review Initiates Coverage On HealthLynked Corp. (HLYK) $0.23.
NAPLES, Fla., Oct. 04, 2017 (GLOBE NEWSWIRE) -- HealthLynked Corp. (HLYK) today announced it has retained Institutional Analyst Inc., to provide coverage to investors...
Bradley Rotter: Cybersecurity: AI, Friend or Foe?
Applied AI Conference 2017
https://youtu.be/VcNXvqdsKMI?si=Ze_a_LHMrkb-4ksk
The Applied AI Conference is a must-attend event for people who are working, researching, building, and investing in Applied Artificial Intelligence...
Added to Watch List $1.32, Dyadic Inc (DYAI) Announces $5 Million Stock Buyback.
CLICK TO VIEW REPORT
Adding Dicerna (DRNA) $3.30 to Watch List.
Adding Dicerna (DRNA) $3.30 to Watch List.
How fun would it be to sell a $3.00 idea (IMMU) at $9.00 you got from us and...
Adding Immunomedics (IMMU) $3.00 to Watch List.
Biotech Stock Review Initiates Coverage.
Immunomedics (IMMU). $3.00 Epic Short Squeeze Inflection Point Nears.
As posted on SeekingAlpha.
CNS Wellness, Leading Brain Research and Treatment Technology Company Hits Ground Running.
“Announces Partnership With Caron Foundation, Ranked Amongst Top 7 Treatment Centers in US with Revenues Approaching $100 million.”
On August 20th CNS-Wellness, a wholly owned...